Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.
about
Antimicrobial Drugs in Fighting against Antimicrobial ResistanceBiofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.5-Hydroxyethyl-3-tetradecanoyltetramic acid represents a novel treatment for intravascular catheter infections due to Staphylococcus aureusIdentification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development.Streptokinase Treatment Reverses Biofilm-Associated Antibiotic Resistance in Staphylococcus aureusEfficacy of Linezolid and Fosfomycin in Catheter-Related Biofilm Infection Caused by Methicillin-Resistant Staphylococcus aureus.Eradication of Staphylococcus aureus Catheter-Related Biofilm Infections Using ML:8 and Citrox.Pseudomonas aeruginosa biofilms in disease.Rescue therapy of difficult-to-treat indwelling central venous catheter-related bacteremias in cancer patients: a review for practical purposes.Antibiotic-lock therapy: a clinical viewpoint.Antimicrobial lock therapy in central-line associated bloodstream infections: a systematic review.Central venous catheters and biofilms: where do we stand in 2017?Evaluation of Different Phenotypic Techniques for the Detection of Slime Produced by Bacteria Isolated from Clinical Specimens.Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.Understanding biofilm formation in intravascular device-related infections.Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol.Anti-biofilm properties of the antimicrobial peptide temporin 1Tb and its ability, in combination with EDTA, to eradicate Staphylococcus epidermidis biofilms on silicone catheters.In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa.Study of in vivo catheter biofilm infections using pediatric central venous catheter implanted in rat.In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.Comparative in vitro efficacies of various antipseudomonal antibiotics based catheter lock solutions on eradication of Pseudomonas aeruginosa biofilms.Biofilms formed by gram-negative bacteria undergo increased lipid a palmitoylation, enhancing in vivo survivalSafety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis.Novel treatment of Staphylococcus aureus device-related infections using fibrinolytic agents.Activity of Amphotericin B and Anidulafungin Combined with Rifampicin, Clarithromycin, Ethylenediaminetetraacetic Acid, N-Acetylcysteine, and Farnesol against Candida tropicalis Biofilms.Preventing biofilm formation and associated occlusion by biomimetic glycocalyxlike polymer in central venous catheters.pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.
P2860
Q26752527-38C45CA0-E958-49A4-A33F-5190DDBD1F6FQ30403958-7D81309C-EB65-45ED-9AF0-E67F320727A8Q30424697-29DAF5EB-03CD-417C-8A95-8A4E7DBF2BC9Q33589815-D855D51B-40B8-48EA-9881-2B11F8C112A0Q33995627-261A09FD-2FFA-4598-9BEC-57D641576723Q36147148-A2588DCC-FCCE-473F-846B-34F8A1C832C5Q37018700-7996115E-3EE0-4AB5-A6BA-E50D9CF0E659Q37287744-5FC0501C-DBB3-4F21-BBB6-82BB5CF36C81Q37687126-01CE10DD-954E-45F5-B178-DAC65F38C889Q38081494-6CA5CCD8-8A16-41B8-A28E-891F064DAB48Q38168929-3E6C3087-5D2E-4A0B-9F9D-5109C4425395Q38346099-BDCF65B6-1D17-409D-A28C-987E7F4EC731Q39240750-8542ED66-B9BD-4106-B588-CF3AB21440B3Q39506059-0E9C6D0A-5349-494E-B164-3A6387BEC70AQ40528075-71FCA812-5657-4C31-9C3F-5DFB7EAE2124Q40585932-8B032E29-9693-48E6-8C49-488F6784CA97Q40605208-A829D5E7-BA81-403D-B5C8-B770D128576AQ40633893-AB797CF4-F436-4675-B2F6-AFC5EC608006Q40670875-BE546FC3-34C8-4171-9232-97C2C57131CCQ40786144-3188BCED-61FC-495B-99ED-A842024585B5Q41466021-6C37CB46-A4C2-4C3F-BB0E-A81713174787Q41725795-5B5654C1-C789-4427-A64C-F56A2B8E1E4DQ41837479-B6D0C2D2-E73B-4E3A-BD3C-5FA378D70136Q42241966-E0DD660A-A6D6-402F-9CA6-0401FE263075Q47285575-01A4D6E7-525B-40F0-8EDF-C6BA9B328FE6Q48523183-DF7D176D-44F9-4530-BF6C-F82DE6283B00Q51737748-52543407-374B-44E6-A6FB-388B03B2CB8CQ53549292-01DBB48D-A02D-4AA6-8A50-2D2EDF8E79E8
P2860
Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Full and broad-spectrum in viv ...... -EDTA antibiotic lock therapy.
@en
type
label
Full and broad-spectrum in viv ...... -EDTA antibiotic lock therapy.
@en
prefLabel
Full and broad-spectrum in viv ...... -EDTA antibiotic lock therapy.
@en
P2093
P2860
P921
P356
P1476
Full and broad-spectrum in viv ...... -EDTA antibiotic lock therapy.
@en
P2093
Ashwini Chauhan
Christophe Beloin
David Lebeaux
Jean-Marc Ghigo
P2860
P304
P356
10.1128/AAC.01606-12
P407
P577
2012-10-01T00:00:00Z